US 8906901
Administration of dipeptidyl peptidase inhibitors
granted A61KA61K31/426A61K31/44
Quick answer
US patent 8906901 (Administration of dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/426, A61K31/44, A61K31/513, A61K38/26